← Back to Search

Behavioural Intervention

Serious Game-based Intervention for Mild Cognitive Impairment

N/A

Recruiting

Led By Sunghoon I Lee, PhD

Research Sponsored by University of Massachusetts, Amherst

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Fifty-five years old and above

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 minutes

Awards & highlights

Study Summary

This trial will test whether a cognitive training game can improve symptoms in patients with mild cognitive impairment.

Who is the study for?

This trial is for people over 55 with mild cognitive issues, scoring between 17 and 25 on the MoCA test. They must be able to use a computer for online games and assessments. It's not suitable for those with major depression, certain neurological conditions, severe hearing or vision loss, or significant arm impairments.Check my eligibility

What is being tested?

The study tests 'Neuro-World' cognitive training games designed to help brain function in patients with mild cognitive impairment. Participants will play these games at home and communicate via videoconferencing for assessments.See study design

What are the potential side effects?

Since this intervention involves playing online games designed to improve cognition, side effects are minimal but may include eye strain or fatigue from prolonged screen time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 55 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Montreal Cognitive Assessment (MoCA)

Secondary outcome measures

Alzheimer's Disease Cooperative Study/Activities of Daily Living scale adapted for mild cognitive impairment patients (ADCS/MCI/ADL24)

Digit Backward Span (DBS)

Digit Forward Span (DFS)

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Game InterventionExperimental Treatment1 Intervention

Study participants play Neuro-World 30 minutes per day, twice a week for 12 weeks in your home settings (24 times).

Group II: No InterventionActive Control1 Intervention

Study participants do not engage in any cognitive training.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Massachusetts, AmherstLead Sponsor

78 Previous Clinical Trials

467,722 Total Patients Enrolled

Rutgers, The State University of New JerseyOTHER

429 Previous Clinical Trials

64,182 Total Patients Enrolled

Université de MontréalOTHER

214 Previous Clinical Trials

102,721 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants will be admitted to the trial?

"Affirmative. According to the clinicaltrials.gov website, this research project is actively recruiting participants. The trial was first listed on February 17th 2022 and recently updated on June 21st 2022. A total of 50 patients must be enrolled at 2 different sites for the study to move forward."

Answered by AI

Is the current cohort of this clinical trial still looking for volunteers?

"Affirmative. The clinical trial registry indicates that this medical research project, which was originally shared on February 17th 2022, is presently recruiting participants. About 50 subjects need to be sourced from 2 different treatment sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

2022. "Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04920123.

All > Mild Cognitive Impairment